730 results on '"Aarsland, Dag"'
Search Results
2. Cardiovascular and lifestyle risk factors of mild cognitive impairment in UK veterans and non-veterans
3. Using Retinal diagnostics as a Biomarker for Neurodegenerative Diseases: Protocol for a systematic review.
4. Depressive symptoms are not associated with predementia CSF amyloid pathology
5. Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum
6. The SLaM Brain Health Clinic: a remote biomarker enhanced memory clinic for patients with mild cognitive impairment within an NHS mental health trust
7. Grey matter networks in women and men with dementia with Lewy bodies
8. Neutrophil-to-lymphocyte ratio and lymphocyte count as an alternative to body mass index for screening malnutrition in older adults living in the community
9. Wrist‐worn actigraphy in agitated late‐stage dementia patients: A feasibility study on digital inclusion
10. European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
11. An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention
12. Interactions between zinc and NRF2 in vascular redox signalling
13. Parkinson's disease psychosis associated with accelerated multi-domain cognitive decline
14. Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)
15. Meeting summary of The NYO3 5th NO-Age/AD meeting and the 1st Norway-UK joint meeting on ageing and dementia: recent progress on the mechanisms and interventional strategies
16. Nutrient Intake and its Association with Appendicular Total Lean Mass, Function and Strength in Older Adults: A Population-Based Study
17. Differential methylation analysis in neuropathologically confirmed dementia with Lewy bodies
18. Is lifetime traumatic brain injury a risk factor for mild cognitive impairment in veterans compared to non-veterans?
19. Temporal Muscle Thickness: A Practical Approximation for Assessing Muscle Mass in Older Adults
20. Linking sarcopenia, brain structure and cognitive performance: a large-scale UK Biobank study
21. Sex differences in brain atrophy in dementia with Lewy bodies
22. Dementia with Lewy bodies: old and new knowledge—Part 2: treatment
23. Dementia with Lewy bodies: old and new knowledge – Part 1: clinical aspects and diagnostics
24. Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia
25. A feasibility study of a 6‐week online technology‐assisted compassion training (T‐ACTS) to improve mental health in older adults living in the UK during the COVID‐19 pandemic
26. CSF AβX‐34 ‐ a new biomarker for amyloid‐related small vessel pathology in early Alzheimer’s Disease
27. Dementia with Lewy bodies Drug Therapies in Clinical Trials: 2022
28. The prioritization of biomarkers in the diagnostic workup of Lewy body disease
29. Grey matter alterations associated with the phenomenology of visual hallucinations in Lewy Body Disease
30. Assessing head muscles measured with MRI as alternative to estimate muscle mass in older persons with dementia
31. Reproducible Python workflow for multi‐site resting‐state EEG analysis: From raw data to group classification
32. Assessing head muscles measured with MRI as alternative to estimate muscle mass in older persons with dementia
33. Patient and caregiver views on participating in clinical trials for behavior problems with Alzheimer’s disease
34. Feasibility of Using Wearable Actigraphy for Behavioural Monitoring in Care Home Residents Living with Moderate to Severe Alzheimer’s Disease and Agitation
35. CSF synapse marker changes in predementia Alzheimer´s Disease: AMPA receptor modulators NPTX2 and NPTXR mediate cognition within A/T/N stages
36. Characteristics associated with progression to probable Dementia with Lewy Bodies in a cohort with late onset psychosis
37. A multimodal digital biomarker of functional deficits in early‐stage Alzheimer’s disease: results of the RADAR‐AD study
38. 4. An innovative clinical trial designed to evaluate the effects of ACI‐24.060 in Alzheimer’s Disease and in Down syndrome (ABATE Study)
39. Assessing risk taking and decision making associated with late‐life onset mild psychotics symptoms in cognitively normal older adults
40. Progress on the Development of the Lewy Body Dementia‐Domain Rating Scale
41. Establishing the contribution of genetic risk loci in the Lewy dody diseases
42. Care homes resilience during the pandemic: changing to adapt.
43. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission
44. Cognitive decline in older adults in the UK during and after the COVID-19 pandemic: a longitudinal analysis of PROTECT study data
45. Specific neuropsychiatric symptoms are associated with functional decline trajectories in Alzheimer’s disease and Lewy body dementia: a five-year follow-up study
46. Developing a core outcome set (COS) for Dementia with Lewy bodies (DLB)
47. Dementia Researchers’ Inside Views on Research Networks and Alignment With Public Research Funding: A Qualitative Study
48. Subjective Cognitive and Communicative Complaints and Health-Related Quality of Life in Parkinson's Disease with and without Mild Cognitive Impairment
49. Subjective Cognitive and Communicative Complaints and Health-Related Quality of Life in Parkinson's Disease with and without Mild Cognitive Impairment
50. The Lewy body dementias
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.